FDA clears Sectra's cardiovascular imaging technology

Sectra AB has received FDA approval for its analysis package for cardiovascular imaging.

The application provides physicians with analysis functions for quantifying arterial stenosis and overall heart function, including tools for quantitative coronary analysis (QCA) and left ventricle analysis (LVA).

Sectra's cardiology applications are designed to allow physicians access to specific clinical tools designed to support the diagnostic process, increase the reproducibility and improve workflow efficiency.

Around the web

GE HealthCare designed the new-look Revolution Vibe CT scanner to help hospitals and health systems embrace CCTA and improve overall efficiency.

Clinicians have been using HeartSee to diagnose and treat coronary artery disease since the technology first debuted back in 2018. These latest updates, set to roll out to existing users, are designed to improve diagnostic performance and user access.

The cardiac technologies clinicians use for CVD evaluations have changed significantly in recent years, according to a new analysis of CMS data. While some modalities are on the rise, others are being utilized much less than ever before.